Seidl K, Hauer B, Schwick N, Ostermeier R, Senges J
Klinischen Elektrophysiologie im Herzzentrum Ludwigshafen.
Fortschr Med. 1997 Nov 30;115(33):24, 27-8, 31.
Catheter ablation is a curative intervention for the treatment of supraventricular, but also ventricular, tachycardias that has proved both safe and effective. In patients with supraventricular tachycardias in underlying WPW syndrome or nodal tachycardia and appreciable symptoms, catheter ablation can be considered the treatment of choice. But many patients with monomorphic ventricular extrasystole that is difficult to control medically experience considerable subjective impairment in their daily life. It is possible that in such patients, too, catheter ablation may, sometime in the future, be used to cure their condition. However, long-term results must first be awaited.
导管消融是一种用于治疗室上性心动过速以及室性心动过速的根治性干预措施，已被证明既安全又有效。对于患有预激综合征或房室结折返性心动过速且有明显症状的室上性心动过速患者，导管消融可被视为首选治疗方法。但是，许多药物难以控制的单形性室性早搏患者在日常生活中会经历相当大的主观不适。在这类患者中，导管消融在未来某个时候也有可能用于治愈他们的疾病。然而，必须首先等待长期结果。
